# ACI Worldwide, Inc.: financial statements, quarterly

ACIW · Nasdaq · CIK 935036 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aciw.md) · [Financials](/companies/aciw/financials.md) · [Filings](/companies/aciw/filings.md) · [Insiders](/companies/aciw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aciw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [363](/filings/0000935036-24-000038.md) | [477 d](/filings/0000935036-26-000011.md) | [316](/filings/0000935036-25-000013.md) | [373](/filings/0000935036-25-000019.md) | [452](/filings/0000935036-25-000031.md) | [453 d](/filings/0000935036-26-000011.md) | [395](/filings/0000935036-26-000021.md) | [401](/filings/0000935036-26-000028.md) | [482](/filings/0000935036-25-000031.md) | [482 d](/filings/0000935036-26-000011.md) | [426](/filings/0000935036-26-000021.md) | [430](/filings/0000935036-26-000028.md) |
| Cost of revenue | $m | [178](/filings/0000935036-24-000038.md) | [182 d](/filings/0000935036-26-000011.md) | [191](/filings/0000935036-25-000013.md) | [203](/filings/0000935036-25-000019.md) | [197](/filings/0000935036-25-000031.md) | [200 d](/filings/0000935036-26-000011.md) | [213](/filings/0000935036-26-000021.md) | [235](/filings/0000935036-26-000028.md) | [223](/filings/0000935036-25-000031.md) | [226 d](/filings/0000935036-26-000011.md) | [228](/filings/0000935036-26-000021.md) | [249](/filings/0000935036-26-000028.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [61.9](/filings/0000935036-24-000038.md) | [172 d](/filings/0000935036-26-000011.md) | [9.6](/filings/0000935036-25-000013.md) | [53.7](/filings/0000935036-25-000019.md) | [123](/filings/0000935036-25-000031.md) | [122 d](/filings/0000935036-26-000011.md) | [58.5](/filings/0000935036-26-000021.md) | [34.9](/filings/0000935036-26-000028.md) | [128](/filings/0000935036-25-000031.md) | [109 d](/filings/0000935036-26-000011.md) | [57.5](/filings/0000935036-26-000021.md) | [44.6](/filings/0000935036-26-000028.md) |
| Interest expense | $m | [19.8](/filings/0000935036-23-000039.md) | [19.8 d](/filings/0000935036-24-000007.md) | [19.0](/filings/0000935036-24-000018.md) | [18.5](/filings/0000935036-24-000030.md) | [18.4](/filings/0000935036-25-000031.md) | [16.6 d](/filings/0000935036-26-000011.md) | [14.7](/filings/0000935036-26-000021.md) | [14.5](/filings/0000935036-26-000028.md) | [14.8](/filings/0000935036-25-000031.md) | [13.8 d](/filings/0000935036-26-000011.md) | [12.2](/filings/0000935036-26-000021.md) | [12.0](/filings/0000935036-26-000028.md) |
| Income tax | $m | [8.8](/filings/0000935036-24-000038.md) | [31.5 d](/filings/0000935036-26-000011.md) | [0.3](/filings/0000935036-25-000013.md) | [9.5](/filings/0000935036-25-000019.md) | [25.9](/filings/0000935036-25-000031.md) | [11.7 d](/filings/0000935036-26-000011.md) | [12.8](/filings/0000935036-26-000021.md) | [5.7](/filings/0000935036-26-000028.md) | [26.9](/filings/0000935036-25-000031.md) | [34.7 d](/filings/0000935036-26-000011.md) | [12.1](/filings/0000935036-26-000021.md) | [7.1](/filings/0000935036-26-000028.md) |
| Net income | $m | [37.9](/filings/0000935036-24-000038.md) | [123 d](/filings/0000935036-26-000011.md) | [(7.8)](/filings/0000935036-25-000013.md) | [30.9](/filings/0000935036-25-000019.md) | [81.4](/filings/0000935036-25-000031.md) | [98.6 d](/filings/0000935036-26-000011.md) | [58.9](/filings/0000935036-26-000021.md) | [12.2](/filings/0000935036-26-000028.md) | [91.3](/filings/0000935036-25-000031.md) | [64.3 d](/filings/0000935036-26-000011.md) | [38.3](/filings/0000935036-26-000021.md) | [31.8](/filings/0000935036-26-000028.md) |
| Diluted EPS | $ per share | [0.35](/filings/0000935036-24-000038.md) | not reported | [(0.07)](/filings/0000935036-25-000013.md) | [0.29](/filings/0000935036-25-000019.md) | [0.77](/filings/0000935036-25-000031.md) | not reported | [0.55](/filings/0000935036-26-000021.md) | [0.12](/filings/0000935036-26-000028.md) | [0.88](/filings/0000935036-25-000031.md) | not reported | [0.37](/filings/0000935036-26-000021.md) | [0.31](/filings/0000935036-26-000028.md) |
| Basic EPS | $ per share | [0.35](/filings/0000935036-24-000038.md) | not reported | [(0.07)](/filings/0000935036-25-000013.md) | [0.29](/filings/0000935036-25-000019.md) | [0.78](/filings/0000935036-25-000031.md) | not reported | [0.56](/filings/0000935036-26-000021.md) | [0.12](/filings/0000935036-26-000028.md) | [0.88](/filings/0000935036-25-000031.md) | not reported | [0.38](/filings/0000935036-26-000021.md) | [0.31](/filings/0000935036-26-000028.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [140](/filings/0000935036-24-000038.md) | [164](/filings/0000935036-26-000011.md) | [183](/filings/0000935036-25-000013.md) | [157](/filings/0000935036-25-000019.md) | [178](/filings/0000935036-25-000031.md) | [216](/filings/0000935036-26-000011.md) | [230](/filings/0000935036-26-000021.md) | [190](/filings/0000935036-26-000028.md) | [199](/filings/0000935036-25-000031.md) | [196](/filings/0000935036-26-000028.md) | [162](/filings/0000935036-26-000021.md) | [167](/filings/0000935036-26-000028.md) |
| Current assets | $m | [1,227](/filings/0000935036-23-000039.md) | [1,407](/filings/0000935036-25-000006.md) | [1,299](/filings/0000935036-24-000018.md) | [1,381](/filings/0000935036-24-000030.md) | [1,086](/filings/0000935036-24-000038.md) | [991](/filings/0000935036-26-000011.md) | [1,209](/filings/0000935036-25-000013.md) | [1,145](/filings/0000935036-25-000019.md) | [1,164](/filings/0000935036-25-000031.md) | [1,089](/filings/0000935036-26-000028.md) | [1,133](/filings/0000935036-26-000021.md) | [1,144](/filings/0000935036-26-000028.md) |
| Total assets | $m | [3,255](/filings/0000935036-23-000039.md) | [3,445](/filings/0000935036-25-000006.md) | [3,300](/filings/0000935036-24-000018.md) | [3,365](/filings/0000935036-24-000030.md) | [3,093](/filings/0000935036-24-000038.md) | [3,025](/filings/0000935036-26-000011.md) | [3,203](/filings/0000935036-25-000013.md) | [3,138](/filings/0000935036-25-000019.md) | [3,161](/filings/0000935036-25-000031.md) | [3,105](/filings/0000935036-26-000028.md) | [3,105](/filings/0000935036-26-000021.md) | [3,095](/filings/0000935036-26-000028.md) |
| Current liabilities | $m | [946](/filings/0000935036-23-000039.md) | [1,037](/filings/0000935036-25-000006.md) | [949](/filings/0000935036-24-000018.md) | [1,044](/filings/0000935036-24-000030.md) | [697](/filings/0000935036-24-000038.md) | [603](/filings/0000935036-26-000011.md) | [805](/filings/0000935036-25-000013.md) | [775](/filings/0000935036-25-000019.md) | [737](/filings/0000935036-25-000031.md) | [706](/filings/0000935036-26-000028.md) | [739](/filings/0000935036-26-000021.md) | [723](/filings/0000935036-26-000028.md) |
| Total liabilities | $m | [2,044](/filings/0000935036-23-000039.md) | [2,120](/filings/0000935036-25-000006.md) | [2,043](/filings/0000935036-24-000018.md) | [2,128](/filings/0000935036-24-000030.md) | [1,763](/filings/0000935036-24-000038.md) | [1,601](/filings/0000935036-26-000011.md) | [1,721](/filings/0000935036-25-000013.md) | [1,745](/filings/0000935036-25-000019.md) | [1,682](/filings/0000935036-25-000031.md) | [1,586](/filings/0000935036-26-000028.md) | [1,604](/filings/0000935036-26-000021.md) | [1,599](/filings/0000935036-26-000028.md) |
| Long-term debt | $m | [987](/filings/0000935036-23-000039.md) | [964](/filings/0000935036-25-000006.md) | [982](/filings/0000935036-24-000018.md) | [973](/filings/0000935036-24-000030.md) | [959](/filings/0000935036-24-000038.md) | [890](/filings/0000935036-26-000011.md) | [811](/filings/0000935036-25-000013.md) | [857](/filings/0000935036-25-000019.md) | [827](/filings/0000935036-25-000031.md) | [777](/filings/0000935036-26-000028.md) | [766](/filings/0000935036-26-000021.md) | [781](/filings/0000935036-26-000028.md) |
| Current portion of debt | $m | [74.4](/filings/0000935036-23-000039.md) | [74.4](/filings/0000935036-25-000006.md) | [34.9](/filings/0000935036-24-000018.md) | [34.9](/filings/0000935036-24-000030.md) | [34.9](/filings/0000935036-24-000038.md) | [34.9](/filings/0000935036-26-000011.md) | [34.9](/filings/0000935036-25-000013.md) | [40.9](/filings/0000935036-25-000019.md) | [40.9](/filings/0000935036-25-000031.md) | [40.9](/filings/0000935036-26-000028.md) | [41.0](/filings/0000935036-26-000021.md) | [41.0](/filings/0000935036-26-000028.md) |
| Shareholders' equity | $m | [1,211](/filings/0000935036-24-000038.md) | [1,324](/filings/0000935036-26-000011.md) | [1,257](/filings/0000935036-25-000019.md) | [1,237](/filings/0000935036-25-000031.md) | [1,330](/filings/0000935036-25-000031.md) | [1,424](/filings/0000935036-26-000028.md) | [1,483](/filings/0000935036-26-000028.md) | [1,393](/filings/0000935036-26-000028.md) | [1,479](/filings/0000935036-25-000031.md) | [1,519](/filings/0000935036-26-000028.md) | [1,501](/filings/0000935036-26-000028.md) | [1,497](/filings/0000935036-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.3 d](/filings/0000935036-24-000038.md) | [85.7 d](/filings/0000935036-26-000011.md) | [123](/filings/0000935036-25-000013.md) | [55.0 d](/filings/0000935036-25-000019.md) | [54.0 d](/filings/0000935036-25-000031.md) | [126 d](/filings/0000935036-26-000011.md) | [78.2](/filings/0000935036-26-000021.md) | [49.8 d](/filings/0000935036-26-000028.md) | [73.0 d](/filings/0000935036-25-000031.md) | [122 d](/filings/0000935036-26-000011.md) | [64.2](/filings/0000935036-26-000021.md) | [70.8 d](/filings/0000935036-26-000028.md) |
| Capital expenditure | $m | [3.4 d](/filings/0000935036-24-000038.md) | [1.0 d](/filings/0000935036-26-000011.md) | [3.2](/filings/0000935036-25-000013.md) | [1.7 d](/filings/0000935036-25-000019.md) | [3.5 d](/filings/0000935036-25-000031.md) | [6.9 d](/filings/0000935036-26-000011.md) | [2.2](/filings/0000935036-26-000021.md) | [2.2 d](/filings/0000935036-26-000028.md) | [3.4 d](/filings/0000935036-25-000031.md) | [5.2 d](/filings/0000935036-26-000011.md) | [3.0](/filings/0000935036-26-000021.md) | [6.9 d](/filings/0000935036-26-000028.md) |
| Share repurchases | $m | [0.0 d](/filings/0000935036-24-000038.md) | [27.6 d](/filings/0000935036-26-000011.md) | [62.5](/filings/0000935036-25-000013.md) | [57.2 d](/filings/0000935036-25-000019.md) | [8.0 d](/filings/0000935036-25-000031.md) | [0.0 d](/filings/0000935036-26-000011.md) | [14.4](/filings/0000935036-26-000021.md) | [119 d](/filings/0000935036-26-000028.md) | [16.3 d](/filings/0000935036-25-000031.md) | [52.6 d](/filings/0000935036-26-000011.md) | [65.3](/filings/0000935036-26-000021.md) | [41.5 d](/filings/0000935036-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [114](/filings/0000935036-23-000039.md) | [108](/filings/0000935036-24-000018.md) | [108](/filings/0000935036-24-000030.md) | [109](/filings/0000935036-24-000038.md) | [107](/filings/0000935036-25-000013.md) | [106](/filings/0000935036-25-000019.md) | [106](/filings/0000935036-25-000031.md) | [107](/filings/0000935036-26-000021.md) | [105](/filings/0000935036-26-000028.md) | [104](/filings/0000935036-25-000031.md) | [103](/filings/0000935036-26-000021.md) | [102](/filings/0000935036-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 100,955,241 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0000935036-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.